Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trialHongzhou Lu, Nanshan Zhong, Tianxiang Zhang et al.|EClinicalMedicine|2024Cited by 23
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171H Zhang, Li Liu, Jing Zhou et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 18
Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II studyChong Wang, Junqi Niu, Fei Kong et al.|EClinicalMedicine|2025Cited by 7